ConductScience.org, home

Paper15389727

QT prolongation through hERG K(+) channel blockade: current knowledge and strategies for the early prediction during drug development.

Recanatini M and 4 others. Med Res Rev, 2005. Cited by 231 papers, by iCite.

Cite this record

ConductScience Library. QT prolongation through hERG K(+) channel blockade: current knowledge and strategies for the early prediction during drug development. Papers, record 15389727. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15389727

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
QT prolongation through hERG K(+) channel blockade: current knowledge and strategies for the early prediction during drug development.
PubMed
Journal
Med Res Rev
PubMed
Year
2005
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
231
iCite
Relative citation ratio, by iCite
6.12
iCite
Revised in PubMed
2013-11-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Recanatini MMaurizio
2Poluzzi EElisabetta
3Masetti MMatteo
4Cavalli AAndrea
5De Ponti FFabrizio

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Long QT SyndromeMajor topic
Potassium Channels, Voltage-GatedMajor topic
Animals
Cation Transport Proteins
Electrocardiography
Ether-A-Go-Go Potassium Channels
Humans
Inhibitory Concentration 50
Models, Biological
Models, Chemical
Potassium
Potassium Channels
Protein Structure, Secondary
Structure-Activity Relationship
Time Factors
Torsades de Pointes

Source PubMed

Download CSV of topics

Cited by85

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 231 citations.

PMIDTitleJournalYearIn PapersSource
42794903Longitudinal Changes in QTc Interval in Cancer Patients After the Initiation of Systemic Therapy: Analysis of the ONCOECHO Study Cohort.Cancers (Basel)2026https://conductscience.org/library/papers/42794903PubMed
42641004Synthesis of 4-Hydroxyacetophenone-Derived Bis-Schiff Bases as Potent Cholinesterase Inhibitors: In Vitro Evaluation, Molecular Docking, DFT, and ADMET Analysis.Chem Biodivers2026https://conductscience.org/library/papers/42641004PubMed
42369237Neuronal safety of Kv11.1 blockers: Patch-clamp and in vitro evaluation with physiologically based pharmacokinetic (PBPK) modeling.Toxicol Rep2026https://conductscience.org/library/papers/42369237PubMed
42105200Designing the Next Generation of Antibiotics: Structure, SAR, and Strategy in Medicinal Chemistry (2000-2025).Med Res Rev2026https://conductscience.org/library/papers/42105200PubMed
41915186In-silico toxicity study of tryptamine, psilocin, psilocybin, N,N-dimethyltryptamine, 5'-methoxy-N,N-dimethyltryptamine and O-acetylpsilocin.Arch Toxicol2026https://conductscience.org/library/papers/41915186PubMed
41871133Multitarget docking and molecular enumeration reveal DdpMPyPEPhU as a potent modulator of cell cycle, glucocorticoid, and estrogen signalling in breast cancer.PLoS One2026https://conductscience.org/library/papers/41871133PubMed
41413149In vitro and in silico evaluation of flavonoids from Erythrina crista-galli with cytotoxic potential against MCF-7 breast cancer cell.Sci Rep2025https://conductscience.org/library/papers/41413149PubMed
41361125
Qualitative and quantitative in silico toxicity profiling of "angel dust": phencyclidine (PCP) analogues as new psychoactive substances (3-HO-PCP, 3-MeO-PCP, 4-MeO-PCP, 3-HO-PCE, 3-MeO-PCE, 4-MeO-PCE).
Arch Toxicol2026https://conductscience.org/library/papers/41361125PubMed
41208201Drug-Induced QT Prolongation: Associations Between Risk Classifications in a Swedish Clinical Decision Support System and Clinical Outcomes.Clin Pharmacol Ther2026https://conductscience.org/library/papers/41208201PubMed
41110013Toxicity of fentanyl (CAS: 437-38-7) and valerylfentanyl (CAS: 122882-90-0): the first integrative in silico toxicology study with clinical and forensic implications.Arch Toxicol2026https://conductscience.org/library/papers/41110013PubMed
40979544Predicting cardiotoxicity in drug development: A deep learning approach.J Pharm Anal2025https://conductscience.org/library/papers/40979544PubMed
39937319Sigma-1 Receptor Specific Biological Functions, Protective Role, and Therapeutic Potential in Cardiovascular Diseases.Cardiovasc Toxicol2025https://conductscience.org/library/papers/39937319PubMed
39875959hERGAT: predicting hERG blockers using graph attention mechanism through atom- and molecule-level interaction analyses.J Cheminform2025https://conductscience.org/library/papers/39875959PubMed
39716240AttenhERG: a reliable and interpretable graph neural network framework for predicting hERG channel blockers.J Cheminform2024https://conductscience.org/library/papers/39716240PubMed
39466134Proton pump inhibitors and cardiovascular risk: a critical review.Future Cardiol2024https://conductscience.org/library/papers/39466134PubMed
39219930Long QT Syndrome With Drugs Used in the Management of Arrhythmias: A Systematic Review.Cureus2024https://conductscience.org/library/papers/39219930PubMed
38892053Toxicity of the New Psychoactive Substance (NPS) Clephedrone (4-Chloromethcathinone, 4-CMC): Prediction of Toxicity Using In Silico Methods for Clinical and Forensic Purposes.Int J Mol Sci2024https://conductscience.org/library/papers/38892053PubMed
38057999Review of machine learning and deep learning models for toxicity prediction.Exp Biol Med (Maywood)2023https://conductscience.org/library/papers/38057999PubMed
37969740Carbazole and tetrahydro-carboline derivatives as dopamine D3 receptor antagonists with the multiple antipsychotic-like properties.Acta Pharm Sin B2023https://conductscience.org/library/papers/37969740PubMed
37934066Contractility measurements for cardiotoxicity screening with ventricular myocardial slices of pigs.Cardiovasc Res2023https://conductscience.org/library/papers/37934066PubMed

See all 85 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ERG2078PubTator's text mininghttps://conductscience.org/library/genes/2078NCBI Gene
KCNH23757PubTator's text mininghttps://conductscience.org/library/genes/3757NCBI Gene
KCNH681033PubTator's text mininghttps://conductscience.org/library/genes/81033NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/15389727

GET https://conductscience.org/api/papers/v1/15389727/cited_by?page=2